GCP
ZSPH

GSA Capital Partners’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

GSA Capital Partners’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,638
Closed -$243K – 2251
2015
Q2 		$243K Buy
+4,638
New +$228K 0.01% 1721

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GSA Capital Partners's ZSPH Position: Q3 2015 in Review

GSA Capital Partners sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q3 2015, closing a stake of 4,638 shares — an estimated $243K sold.

GSA Capital Partners first reported a position in ZSPH in Q2 2015 and held it in 1 quarter. The position peaked at $243K in Q2 2015. 124 funds tracked by Wall St. Rank hold ZSPH as of Q3 2015.

  • GSA Capital Partners reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q3 2015 after selling out during the quarter.
  • GSA Capital Partners sold 4,638 ZS PHARMA INC COMS TK (DE) shares in Q3 2015, an estimated $243K.
  • GSA Capital Partners first reported a position in ZS PHARMA INC COMS TK (DE) in Q2 2015 and held it in 1 quarter.
  • GSA Capital Partners's ZS PHARMA INC COMS TK (DE) position peaked at $243K in Q2 2015.
  • 124 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q3 2015.

Based on GSA Capital Partners's 13F filing for Q3 2015, filed 13 Nov 2015.